APO Research
Talk to an analyst

APO RESEARCH · REPORT

Exocrine Pancreatic Insufficiency Therapeutic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Exocrine Pancreatic Insufficiency Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026185 pages

Choose your research edition.

Industry ResearchExocrine Pancreatic Insufficiency Therapeutic Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Exocrine Pancreatic Insufficiency Therapeutic Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Exocrine Pancreatic Insufficiency Therapeutic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exocrine Pancreatic Insufficiency Therapeutic Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Exocrine Pancreatic Insufficiency Therapeutic Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Exocrine Pancreatic Insufficiency Therapeutic market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Exocrine Pancreatic Insufficiency Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Exocrine Pancreatic Insufficiency Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Exocrine Pancreatic Insufficiency Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Exocrine Pancreatic Insufficiency Therapeutic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Exocrine Pancreatic Insufficiency Therapeutic include Janssen Pharmaceuticals, AbbVie, CHIESI Farmaceutici S.p.A., AzurRx and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Exocrine Pancreatic Insufficiency Therapeutic market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Exocrine Pancreatic Insufficiency Therapeutic and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Exocrine Pancreatic Insufficiency Therapeutic revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Exocrine Pancreatic Insufficiency Therapeutic market size, projected growth trends, production technologies, key applications, and end-use industries.

Exocrine Pancreatic Insufficiency Therapeutic Segment by Company

Janssen Pharmaceuticals

AbbVie

CHIESI Farmaceutici S.p.A.

AzurRx

Allergan

Exocrine Pancreatic Insufficiency Therapeutic Segment by Type

Pancreatic Enzyme Replacement Therapy

Nutritional Therapy

Exocrine Pancreatic Insufficiency Therapeutic Segment by Application

Hospital Pharmacies

Retail Pharmacies & Drug Stores

Others

Exocrine Pancreatic Insufficiency Therapeutic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exocrine Pancreatic Insufficiency Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exocrine Pancreatic Insufficiency Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exocrine Pancreatic Insufficiency Therapeutic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Exocrine Pancreatic Insufficiency Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Exocrine Pancreatic Insufficiency Therapeutic industry.

Chapter 3: Detailed analysis of Exocrine Pancreatic Insufficiency Therapeutic companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exocrine Pancreatic Insufficiency Therapeuticrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Pancreatic Enzyme Replacement Therapy Table 3. Key Players of Nutritional Therapy Table 4. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Pharmacies Table 6. Key Players of Retail Pharmacies & Drug Stores Table 7. Key Players of Others Table 8. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Region (2021-2026) Table 11. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Region (2027-2032) Table 13. Exocrine Pancreatic Insufficiency Therapeutic Industry Trends Table 14. Exocrine Pancreatic Insufficiency Therapeutic Industry Drivers Table 15. Exocrine Pancreatic Insufficiency Therapeutic Industry Opportunities and Challenges Table 16. Exocrine Pancreatic Insufficiency Therapeutic Industry Restraints Table 17. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Company (2021-2026) Table 19. Global Exocrine Pancreatic Insufficiency Therapeutic Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Exocrine Pancreatic Insufficiency Therapeutic Key Company Head Office and Area Served Table 21. Global Exocrine Pancreatic Insufficiency Therapeutic Company, Product Type & Application Table 22. Global Exocrine Pancreatic Insufficiency Therapeutic Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Exocrine Pancreatic Insufficiency Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2021-2026) Table 29. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2027-2032) Table 30. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Application (2021-2026) Table 34. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Application (2027-2032) Table 35. Janssen Pharmaceuticals Company Information Table 36. Janssen Pharmaceuticals Business Overview Table 37. Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio Table 39. Janssen Pharmaceuticals Recent Development Table 40. AbbVie Company Information Table 41. AbbVie Business Overview Table 42. AbbVie Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. AbbVie Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio Table 44. AbbVie Recent Development Table 45. CHIESI Farmaceutici S.p.A. Company Information Table 46. CHIESI Farmaceutici S.p.A. Business Overview Table 47. CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio Table 49. CHIESI Farmaceutici S.p.A. Recent Development Table 50. AzurRx Company Information Table 51. AzurRx Business Overview Table 52. AzurRx Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AzurRx Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio Table 54. AzurRx Recent Development Table 55. Allergan Company Information Table 56. Allergan Business Overview Table 57. Allergan Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Allergan Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio Table 59. Allergan Recent Development Table 60. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 61. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 62. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 63. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 64. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 65. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026) Table 66. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032) Table 67. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 68. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 69. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 70. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 71. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026) Table 73. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032) Table 74. China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 75. China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 76. China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 77. China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 78. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 79. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 80. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 81. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026) Table 84. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032) Table 85. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026) & (US$ Million) Table 86. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032) & (US$ Million) Table 87. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026) & (US$ Million) Table 88. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032) & (US$ Million) Table 89. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026) Table 91. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032) Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Exocrine Pancreatic Insufficiency Therapeutic Product Image Figure 2. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type: 2025 VS 2032 Figure 4. Pancreatic Enzyme Replacement Therapy Image Figure 5. Nutritional Therapy Image Figure 6. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application: 2025 VS 2032 Figure 8. Hospital Pharmacies Image Figure 9. Retail Pharmacies & Drug Stores Image Figure 10. Others Image Figure 11. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 13. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Exocrine Pancreatic Insufficiency Therapeutic Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Exocrine Pancreatic Insufficiency Therapeutic Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Type (2021-2032) Figure 20. Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Exocrine Pancreatic Insufficiency Therapeutic Revenue Market Share by Application (2021-2032) Figure 22. North America Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 23. North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032) Figure 24. North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032) Figure 25. North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032) Figure 26. United States Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 27. Canada Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 29. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 30. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032) Figure 31. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032) Figure 32. Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032) Figure 33. Germany Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 34. France Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 36. Italy Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 37. Russia Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 39. China Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 40. China Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032) Figure 41. China Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032) Figure 42. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 43. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032) Figure 44. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032) Figure 45. Asia Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032) Figure 46. Japan Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 50. India Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 51. Australia Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032) Figure 56. Brazil Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 61. UAE Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 63. Chile Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Pancreatic Enzyme Replacement Therapy
  • Nutritional Therapy
Applications
  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Others
Companies covered
  • Janssen Pharmaceuticals
  • AbbVie
  • CHIESI Farmaceutici S.p.A.
  • AzurRx
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Pancreatic Enzyme Replacement Therapy
  5. 1.2.3 Nutritional Therapy
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital Pharmacies
  9. 1.3.3 Retail Pharmacies & Drug Stores
  10. 1.3.4 Others
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Exocrine Pancreatic Insufficiency Therapeutic Growth Trends by Region
  13. 1.5.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2021-2026)
  15. 1.5.3 Exocrine Pancreatic Insufficiency Therapeutic Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Exocrine Pancreatic Insufficiency Therapeutic Market Dynamics
  1. 2.1 Exocrine Pancreatic Insufficiency Therapeutic Industry Trends
  2. 2.2 Exocrine Pancreatic Insufficiency Therapeutic Industry Drivers
  3. 2.3 Exocrine Pancreatic Insufficiency Therapeutic Industry Opportunities and Challenges
  4. 2.4 Exocrine Pancreatic Insufficiency Therapeutic Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Exocrine Pancreatic Insufficiency Therapeutic Revenue by Company (2021-2026)
  2. 3.2 Global Exocrine Pancreatic Insufficiency Therapeutic Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Exocrine Pancreatic Insufficiency Therapeutic Key Company Head office and Area Served
  4. 3.4 Global Exocrine Pancreatic Insufficiency Therapeutic Company, Product Type & Application
  5. 3.5 Global Exocrine Pancreatic Insufficiency Therapeutic Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Exocrine Pancreatic Insufficiency Therapeutic Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Exocrine Pancreatic Insufficiency Therapeutic Tier 1, Tier 2, and Tier 3
4 Exocrine Pancreatic Insufficiency Therapeutic Market by Type
  1. 4.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2032)
  3. 4.3 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Share by Type (2021-2032)
5 Exocrine Pancreatic Insufficiency Therapeutic Market by Application
  1. 5.1 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2032)
  3. 5.3 Global Exocrine Pancreatic Insufficiency Therapeutic Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Janssen Pharmaceuticals
  2. 6.1.1 Janssen Pharmaceuticals Company Information
  3. 6.1.2 Janssen Pharmaceuticals Business Overview
  4. 6.1.3 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Janssen Pharmaceuticals Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio
  6. 6.1.5 Janssen Pharmaceuticals Recent Developments
  7. 6.2 AbbVie
  8. 6.2.1 AbbVie Company Information
  9. 6.2.2 AbbVie Business Overview
  10. 6.2.3 AbbVie Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 AbbVie Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio
  12. 6.2.5 AbbVie Recent Developments
  13. 6.3 CHIESI Farmaceutici S.p.A.
  14. 6.3.1 CHIESI Farmaceutici S.p.A. Company Information
  15. 6.3.2 CHIESI Farmaceutici S.p.A. Business Overview
  16. 6.3.3 CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 CHIESI Farmaceutici S.p.A. Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio
  18. 6.3.5 CHIESI Farmaceutici S.p.A. Recent Developments
  19. 6.4 AzurRx
  20. 6.4.1 AzurRx Company Information
  21. 6.4.2 AzurRx Business Overview
  22. 6.4.3 AzurRx Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AzurRx Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio
  24. 6.4.5 AzurRx Recent Developments
  25. 6.5 Allergan
  26. 6.5.1 Allergan Company Information
  27. 6.5.2 Allergan Business Overview
  28. 6.5.3 Allergan Exocrine Pancreatic Insufficiency Therapeutic Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Allergan Exocrine Pancreatic Insufficiency Therapeutic Product Portfolio
  30. 6.5.5 Allergan Recent Developments
7 North America
  1. 7.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032)
  2. 7.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
  3. 7.2.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026)
  4. 7.2.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032)
  5. 7.2.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032)
  6. 7.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
  7. 7.3.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026)
  8. 7.3.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032)
  9. 7.3.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032)
  10. 7.4 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
  11. 7.4.1 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026)
  13. 7.4.3 North America Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032)
  14. 7.4.4 North America Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032)
  2. 8.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
  3. 8.2.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026)
  4. 8.2.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032)
  5. 8.2.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032)
  6. 8.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
  7. 8.3.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026)
  8. 8.3.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032)
  9. 8.3.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032)
  10. 8.4 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
  11. 8.4.1 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026)
  13. 8.4.3 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032)
  14. 8.4.4 Europe Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032)
  2. 9.2 China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
  3. 9.2.1 China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026)
  4. 9.2.2 China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032)
  5. 9.2.3 China Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032)
  6. 9.3 China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
  7. 9.3.1 China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026)
  8. 9.3.2 China Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032)
  9. 9.3.3 China Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032)
  2. 10.2 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
  3. 10.2.1 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026)
  4. 10.2.2 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032)
  5. 10.2.3 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032)
  6. 10.3 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
  7. 10.3.1 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026)
  8. 10.3.2 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032)
  9. 10.3.3 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032)
  10. 10.4 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
  11. 10.4.1 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026)
  13. 10.4.3 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032)
  14. 10.4.4 Asia Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Exocrine Pancreatic Insufficiency Therapeutic Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst